Achieving Value in Substance Use Disorder Treatment: Paying for What Works (and Not Paying for What Doesn’t): Workshop Summary
More than 100 policymakers, practitioners, and researchers discussed and debated how payment policy can promote evidence-based, cost-effective substance use disorder treatment, in a recent workshop hosted by the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV and HIV (CHERISH) and the Leonard Davis Institute of Health Economics at the University of […]
Increased number of children entering the foster care due to parental drug use
In a recent study published in JAMA Pediatrics, CHERISH Pilot Grant Recipient Angelica Meinhofer examined national trends in foster care entries attributable to parental drug use between 2000 and 2017. There were approximately 5 million foster care entries between 2000 and 2017, 23.38% percent of which were attributable to parental drug use. Moreover, the number of […]
Progress of “Netflix” subscription model negotiations to pay for HCV Treatment
In 2018, the state of Louisiana spent approximately $35 million to treat 1,000 individuals with chronic Hepatitis C Virus (HCV). Unfortunately, these 1,000 treated individuals comprise only about 1% of the state’s 90,000 individuals living with HCV, including about 39,000 covered by the state’s Medicaid program or prison system. Treating everyone would cost more than […]
CHERISH Investigators and Research Affiliates Support NIDA Justice Community Opioid Innovation Network (JCOIN)
On July 24 2019, the National Institute on Drug Abuse (NIDA) announced twelve grants totaling approximately $155 million for the Justice Community Opioid Innovation Network (JCOIN) as part of the greater NIDA HEAL initiative. JCOIN will establish a network of 10 clinical research institutions, a Methodology and Advanced Analytics Resource Center (MAARC), and a Coordination and Translation Center (CTC) that […]
CHERISH Workshop Addresses an ‘Unfortunate Reality’ of the Addiction Treatment Industry
Funded by the National Institute on Drug Abuse and established in 2015, CHERISH is a five year collaboration of researchers from the Leonard Davis Institute of Health Economics (LDI) of the University of Pennsylvania, Weill Cornell Medical College, Boston Medical Center, and the University of Miami. Their work is focused on studying the health economics […]
Care Integration of Hepatitis C and Opioid Use Disorder Treatment is Cost-Effective and Improves Health Outcomes
People who inject drugs (PWID) often become infected with HIV and hepatitis C virus (HCV). While hepatitis C can be successfully treated with medication, care is often fragmented and rarely integrated within one program or setting. Two recent studies by CHERISH researchers modeled economic and health outcomes for PWID and found evidence of synergistic benefits […]
No Safe Dose for That First Opioid Prescription
LDI Senior Fellows Zack Meisel, Benjamin Sun, and colleagues have a striking and sobering chart in a recent Annals of Emergency Medicine article on initial opioid prescriptions in the emergency department. They tracked how many “opioid-naïve” patients (i.e., those without a record of opioid use in the previous year) had persistent or high-risk opioid prescription use in the subsequent […]
Buprenorphine for Opioid Use Disorder Lowers Overdose Risk in Commercially Insured Individuals
“Medications for opioid use disorder saves lives.” That’s the title and conclusion of a recent report by the National Academies of Sciences, Engineering and Medicine, based on a review of the scientific evidence. In a new study in Drug and Alcohol Dependence, CHERISH investigators Jake Morgan, Bruce Schackman and Benjamin Linas add to this evidence base by […]
Angélica Meinhofer, Margaret Lowenstein and Rachel Epstein Awarded Fifth Cycle of CHERISH Pilot Grant Funding
Angélica Meinhofer, PhD Dr. Angélica Meinhofer is an Instructor in the Department of Healthcare Policy & Research at Weill Cornell Medical College. She completed her doctorate in Economics at Brown University and previously worked as a Research Economist at RTI International’s Behavioral Health Services, Policy and Economics Research Program where she designed and conducted evaluations […]
Neonatal Abstinence Syndrome and the Opioid Crisis: Paying Attention to Social Context
As you likely continue to read in your local news or experience in your community, the United States is in the midst of a deadly drug overdose and addiction crisis. In fact, overdoses claimed the lives of 70,000 individuals in 2017—more than two-thirds of those overdoses were linked to opioids. While drug overdoses disproportionately affect young adults, there […]
NIH funds HEALing Communities Study in Four States
On April 18, the National Institute on Drug Abuse (NIDA) together with the Substance Abuse and Mental Health Services Administration (SAMHSA) announced research sites in four states will receive funding as part of the Helping to End Addiction Long-term (HEAL) Initiative HEALing Communities Study. Each state will engage stakeholders and researchers across 15 communities in their […]
Using the 340B Drug Pricing Program to Support Primary Care-Based Hepatitis C Treatment in a Safety-Net Hospital Patient-Centered Medical Home
Over 2 million people in the US had chronic hepatitis C (HCV) infection during 2013- 2016, and HCV remains a leading cause of morbidity and mortality in the United States. Expanding HCV treatment in primary care would improve treatment access and follow-up but is resource intensive, requiring significant staff support. Using a budget impact analysis, a new study […]
Engage with CHERISH
Submit a Consultation Request or Contact Us to learn more about how CHERISH can support your research or policy goals.